Related Experiment Video
Updated: Apr 15, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
The development or exacerbation of eating disorder symptoms after topiramate initiation
Jocelyn Lebow1, Jeffrey A Chuy2, Kyle Cedermark3
1Departments of Psychiatry and Psychology and Departments of Psychiatry and Behavioral Sciences and j.lebow@med.miami.edu.
Abstract:
The Food and Drug Administration recently approved topiramate for migraine prevention in adolescents. Given the well-established appetite-suppressant side effects of topiramate, as well as data suggesting a potential comorbidity between migraine and eating disorders, susceptible young migraine patients may be at a greater risk for the development or worsening of eating disorder symptoms with topiramate therapy. This case series comprises 7 adolescent patients in whom serious eating disorders developed or were exacerbated after the initiation of topiramate therapy. Clinical characteristics of these patients are highlighted. In addition, this case series provides guidelines for providers to use in assessing eating disorders before prescribing topiramate for migraine prevention in adolescents.
Related Concept Videos
Bulimia Nervosa
Binge Eating Disorders
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...

